-
2
-
-
0019163001
-
-
Freidinger R.M., Veber D.F., Perlow D.S., Brooks J.R., and Saperstein R. Science 210 (1980) 656
-
(1980)
Science
, vol.210
, pp. 656
-
-
Freidinger, R.M.1
Veber, D.F.2
Perlow, D.S.3
Brooks, J.R.4
Saperstein, R.5
-
3
-
-
0026480590
-
-
Valle G., Kazmierski W.M., Crisma M., Bonora G.M., Toniolo C., and Hruby V.J. Int. J. Peptide Protein Res. 40 (1992) 222
-
(1992)
Int. J. Peptide Protein Res.
, vol.40
, pp. 222
-
-
Valle, G.1
Kazmierski, W.M.2
Crisma, M.3
Bonora, G.M.4
Toniolo, C.5
Hruby, V.J.6
-
5
-
-
0030027103
-
-
Tourwe D., Verschueren K., Frycia A., Davis P., Porreca F., Hruby V.J., Toth G., Jasper H., Verheyden P., and Van Binst G. Biopolymers 38 (1996) 1
-
(1996)
Biopolymers
, vol.38
, pp. 1
-
-
Tourwe, D.1
Verschueren, K.2
Frycia, A.3
Davis, P.4
Porreca, F.5
Hruby, V.J.6
Toth, G.7
Jasper, H.8
Verheyden, P.9
Van Binst, G.10
-
8
-
-
0026587977
-
-
de Laszlo S.E., Bush B.L., Doyle J.J., Greenlee W.J., Hangauer D.G., Halgren T.A., Lynch R.J., Schorn T.W., and Siegl P.K.S. J. Med. Chem. 35 (1992) 833
-
(1992)
J. Med. Chem.
, vol.35
, pp. 833
-
-
de Laszlo, S.E.1
Bush, B.L.2
Doyle, J.J.3
Greenlee, W.J.4
Hangauer, D.G.5
Halgren, T.A.6
Lynch, R.J.7
Schorn, T.W.8
Siegl, P.K.S.9
-
9
-
-
0034613359
-
-
Casimir J.R., Tourwe D., Iterbeke K., Giuchard G., and Briand J.P. J. Org. Chem. 65 (2000) 6487-6492
-
(2000)
J. Org. Chem.
, vol.65
, pp. 6487-6492
-
-
Casimir, J.R.1
Tourwe, D.2
Iterbeke, K.3
Giuchard, G.4
Briand, J.P.5
-
10
-
-
0037071225
-
-
Ruzza P., Caldern A., Osler A., Elardo S., and Borin G. Tetrahedron Lett. 43 (2002) 3769-3771
-
(2002)
Tetrahedron Lett.
, vol.43
, pp. 3769-3771
-
-
Ruzza, P.1
Caldern, A.2
Osler, A.3
Elardo, S.4
Borin, G.5
-
14
-
-
0034838172
-
-
For exceptionally mild catalysts for Heck reactions, see:
-
For exceptionally mild catalysts for Heck reactions, see:. Littke A.F., and Fu G.C. J. Am. Chem. Soc. 123 (2001) 6989
-
(2001)
J. Am. Chem. Soc.
, vol.123
, pp. 6989
-
-
Littke, A.F.1
Fu, G.C.2
-
18
-
-
33947126994
-
-
NMR experiments were performed on a Bruker 500 MHz spectrometer equipped with a TXI cryo probe.
-
-
-
-
19
-
-
33947123149
-
-
note
-
2) in 56% yield.
-
-
-
-
20
-
-
33947132655
-
-
note
-
2 @ 150 Bar and @ 35 °C as mobile phase at a flow rate of 2.0 mL/min. Absorbance was measured @ 220 nm and 5 μL of 1 mg/mL of 6a or 7a in ethanol was injected. Compound 6a had a retention time of 11.91 min and an enantiomeric excess of 6a was determined to be 99.4%. Compound 7a had a retention time of 14.2 min and an enantiomeric excess of 7b was determined to be 99.9%.
-
-
-
-
21
-
-
16844386126
-
-
Chan C., Heid R., Zheng S., Guo J., Zhou B., Furuuchi T., and Danishefsky S.J. J. Am. Chem. Soc. 127 (2005) 4596
-
(2005)
J. Am. Chem. Soc.
, vol.127
, pp. 4596
-
-
Chan, C.1
Heid, R.2
Zheng, S.3
Guo, J.4
Zhou, B.5
Furuuchi, T.6
Danishefsky, S.J.7
-
22
-
-
33746299718
-
-
Zheng S., Chan C., Furuuchi T., Wright B.J.D., Zhou B., and Danishefsky S.J. Angew. Chem., Int. Ed. 45 (2006) 1754
-
(2006)
Angew. Chem., Int. Ed.
, vol.45
, pp. 1754
-
-
Zheng, S.1
Chan, C.2
Furuuchi, T.3
Wright, B.J.D.4
Zhou, B.5
Danishefsky, S.J.6
-
24
-
-
33947173185
-
-
note
-
2 @ 150 Bar and @ 35 °C as mobile phase at a flow rate of 2.0 mL/min. Absorbance was measured @ 220 nm and 5 μL of 1 mg/mL of 6b or 7b in ethanol was injected. Compound 6b had a retention time of 14.2 min and an enantiomeric excess of 6b was determined to be 97.7%. Compound 7b had a retention time of 15.8 min and an enantiomeric excess of 7b was determined to be 99.5%.
-
-
-
-
25
-
-
33947102061
-
-
note
-
2 @ 150 Bar and @ 35 °C as mobile phase at a flow rate of 2.0 mL/min. Absorbance was measured @ 220 nm and 5 μL of 1 mg/mL of 8a in ethanol was injected. Compound 8a had a retention time of 10.0 min and an enantiomeric excess of 8a was determined to be 96.2%. Compound 8b had a retention time of 12.6 min and an enantiomeric excess of 8b was determined to be 99.0%.
-
-
-
-
26
-
-
33947153817
-
-
note
-
4: 487.2597. Obtained: 487.2577.
-
-
-
-
27
-
-
33947116837
-
-
note
-
+.
-
-
-
|